See More StocksHome

PR

Permian Resources Corporation

Show Trading View Graph

Mentions (24Hr)

3

-40.00% Today

Reddit Posts

r/pennystocksSee Post

$EQ Cash-Rich Penny Stocks Hedge Funds Are Buying - Equillium

r/pennystocksSee Post

$CVKD - Phase3 Bio stock -Will be on day 7 out of 10 to gain compliance this week.

r/pennystocksSee Post

CVKD - Bio - Phase 3 - 25 months Cash - No Debt - Keep watch on next week's catalyst.

r/smallstreetbetsSee Post

Lift Power Ltd (CSE: LIFT, OTCQX: LIFFF, Frankfurt: WS0) - Unlocking A Promising Junior Miner

r/pennystocksSee Post

$CBDW News out. 1606 Corp.'s AI Chatbot Generates Immediate Revenue Growth from New ISO Partnership

r/stocksSee Post

How do you guys research or find growth stocks?

r/pennystocksSee Post

1606 Corp (Stock Symbol: CBDW): A trailblazer in AI-driven merchandising chatbots

r/pennystocksSee Post

PharmaTher Holdings Ltd. ($PHRRF OTC)

r/stocksSee Post

Where should I invest in Index Fund/Mutual Fund: Canadian Stock Market Or USA's ?

r/investingSee Post

Where should I invest in Index Fund/Mutual Fund: Canadian Stock Market Or USA's

r/WallStreetbetsELITESee Post

IGPK insane OTC merger, JFH with 50M app downloads😳 DD inside!

r/WallstreetbetsnewSee Post

IGPK crazy OTC merger, JFH with 50M app downloads😳 (DD) *MUST READ*

r/pennystocksSee Post

IGPK craziest OTC merger, JFH over 50M app downloads *MUST READ* Research (DD)

r/pennystocksSee Post

$EQ Equillium - Unique pipeline: Acute Graft, Lupus, Alopecia

r/wallstreetbetsSee Post

Insider Sells on OpenDoor (OPEN)

r/wallstreetbetsSee Post

Trading McDonalds options based on the health status of Don Gorske

r/pennystocksSee Post

$CBDW News out. AI is gonna be huge in 2024 "1606 Corp. Accounts Skyrocket After December AI ChatBot Launch Leading to Expected Profitability in 2024"

r/pennystocksSee Post

$AEMC Unveils Promising Discoveries: High-Grade Nickel and Copper Abound in Nikolai Nickel Project

r/pennystocksSee Post

The whole IR _ versus _ PR thing

r/wallstreetbetsSee Post

Boeing Safety Crisis part 2 - why I give a damn and you should too

r/wallstreetbetsSee Post

RILY: Shorts are crowded, someone’s gonna get pounded

r/pennystocksSee Post

OTC Pink: CBDW PR 1606 Corp. CEO Attends Consumer Electronics Show (CES) For Collaboration Meetings

r/ShortsqueezeSee Post

VETCOMM Joins Prestigious Client List, Retains Premier Public Relations Firm BLAZE PR as It Readies for Marketing Launch

r/pennystocksSee Post

$CBDW News 1606 Corp. CEO Attends Consumer Electronics Show (CES) For Collaboration Meetings

r/wallstreetbetsSee Post

SPEC Anyone here in this? Carbon dioxide reduction company read article

r/wallstreetbetsSee Post

Unity3d laid off 1/3 of its employees realizing it invalidated all it's contracts & users don't even have to pay anymore. Bankruptcy future?

r/wallstreetbetsSee Post

Bitcoin Bros (like me) Dumb for Falling for the SEC Tweet

r/WallStreetbetsELITESee Post

Mining in Iceland with St-Georges Eco-Mining (CSE: SX) (OTCQB: SXOOF) (FSE:85G1)

r/wallstreetbetsSee Post

[DD] Here's what you're missing on the Boeing Safety Crisis

r/ShortsqueezeSee Post

$FSR HAS ITS OWN FORUM! Make a home for your favorite Ticker

r/pennystocksSee Post

ATOS - Summary PR

r/pennystocksSee Post

$NXGB NEWS OUT NxGen Brands, Inc. Proudly Announces the Successful Closing of "Mad House Innovations" Acquisition

r/smallstreetbetsSee Post

Mining in Iceland with St-Georges Eco-Mining (CSE: SX) (OTCQB: SXOOF) (FSE:85G1)

r/pennystocksSee Post

Equillium $EQ DD

r/ShortsqueezeSee Post

$CDIO PART 4 American Medical Association Grants Cardio Diagnostics A Dedicated CPT PLA Reimbursement Code For Epi+Gen CHD, An AI-Powered Test For Assessing The Probability Of A Heart Attack Or Coronary Heart Disease Event

r/ShortsqueezeSee Post

$MULN CTB 203% No volume this morning. PR to send it.

r/ShortsqueezeSee Post

$FSR - Reversal thesis still tracking beautifully (IMHO)

r/ShortsqueezeSee Post

Parazero $PRZO looking like shorts are crowded again watch for a PR drop to make them scurry again.

r/RobinHoodPennyStocksSee Post

BRSE updates Float/ Verifies Profile / Finalized Acquisition

r/pennystocksSee Post

$BRSE Updated Float Acquisition Complete

r/wallstreetbetsSee Post

Bitcoin ETF Will Actually Be Worse For Crypto

r/stocksSee Post

$IINN, is there good potential for FDA approval?

r/ShortsqueezeSee Post

SqueezeFinder Update - Dec 28th 2023

r/pennystocksSee Post

$SONX is no joke

r/wallstreetbetsSee Post

MARA MARA On The Wall You’re About To Lose It All

r/wallstreetbetsSee Post

Everyone Who Likes MARA Is Getting Coal For Christmas

r/pennystocksSee Post

$SONX - The Gift That Keeps on Giving (300%+ This Week)

r/ShortsqueezeSee Post

Might drop my FSR position. Thoughts?

r/pennystocksSee Post

$SAPX NEWS OUT Seven Arts Entertainment Announces Feature Film Production Agreement

r/investingSee Post

Need Investing advice, being an Immigrant in US

r/pennystocksSee Post

$TWOH CSE: $TWOH Older news but well worth considering when you combine it with how the company is positioning itself for 2024 and the Canadian food market.

r/pennystocksSee Post

Mining in Iceland with St-Georges Eco-Mining (CSE: SX) (OTCQB: SXOOF) (FSE:85G1)

r/pennystocksSee Post

Two Stocks Under $0.02 with a fundamental story: $CUBT and $VISM

r/WallStreetbetsELITESee Post

Anyone heard of African Agriculture?

r/ShortsqueezeSee Post

$PAPL EARNINGS RELEASED STOCK RISING

r/wallstreetbetsSee Post

Highly Regarded - Blackstone’s 2023 Holiday Video: The Alternatives Era

r/smallstreetbetsSee Post

Cell Signaling Technology Leverages Integrated Cyber's Employee-Focused Cybersecurity Service (CSE: ICS)

r/smallstreetbetsSee Post

Cell Signaling Technology Leverages Integrated Cyber's Employee-Focused Cybersecurity Service (CSE: ICS)

r/stocksSee Post

Why are Zara's stocks bullish despite a global backlash after a campaign backfired?

r/pennystocksSee Post

ABQQ One crazy stock DD inside *Must Read*

r/smallstreetbetsSee Post

TKVR Financials look like a dream, exciting business. Research (DD) *MUST READ*

r/smallstreetbetsSee Post

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on December 7, 2023

r/pennystocksSee Post

Zomedica stock ready for a movement.

r/pennystocksSee Post

Cell Signaling Technology Leverages Integrated Cyber's Employee-Focused Cybersecurity Service (CSE: ICS)

r/ShortsqueezeSee Post

ARE THE BACK TO BACK $NEGG POSTS TAKING AWAY FROM OTHER POSSIBLE OPPORTUNITIES?

r/ShortsqueezeSee Post

$CYTO UP 180% STANDARD UP ADDITIONAL .12 AH @ .76

r/pennystocksSee Post

Will CAUD follow YOSH?

r/smallstreetbetsSee Post

NxGen Brands, Inc. Sets Out Strategic Vision for Growth in 2024

r/StockMarketSee Post

How to determine the starting price of a triangular reverse merger? Are any current examples in the stock market?

r/stocksSee Post

How to determine the starting price of a triangular reverse merger? Are any current examples in the stock market?

r/ShortsqueezeSee Post

$SONG UPDATED BULLISH NEWS (follow up from initial post)

r/smallstreetbetsSee Post

$TLIF on news watch

r/ShortsqueezeSee Post

A bullish case (w/DD) for Fisker FSR (SI: 41%)

r/pennystocksSee Post

TKVR (DD) *Must Read* Financials look like a dream

r/smallstreetbetsSee Post

TMGI ~ from yesterdays PR.

r/pennystocksSee Post

Red Flag: Put your money somewhere other than Mullen Stock.

r/wallstreetbetsSee Post

Unpopular opinion: Elon Musk buying Twitter was a genius move

r/ShortsqueezeSee Post

$WIMI .6302 Interesting Read and Possibly Long Hold

r/pennystocksSee Post

Surge Battery Metals ($NILI) Announces Insider Buying of 500,000 Shares, Reassuring The Market 🚀

r/ShortsqueezeSee Post

POSSIBLE BREAKOUT: $SONG just had more than half of its OS removed. CEO posted that an official PR is being is released tomorrow morning at 8am. Plus the price just broke past a major resistance from an all time low!!! Enterprise Value $106,649,000. View post for images of Chart 1D, 5D, 1M, 1Y

r/pennystocksSee Post

$INKW News dropped. Great PR here. Greene Concepts Prepares for Banner Year in 2024 and Company’s Highest Growth Levels

r/pennystocksSee Post

MBRX - Moleculin Presents Positive Preliminary Efficacy Findings from Phase 1B/2 Clinical Trial Demonstrating 64% Stable Disease Rate Through Two Cycles of Annamycin for the Treatment of Soft Tissue Sarcomas (STS) Lung Metastases

r/pennystocksSee Post

$TWOH News out. Two Hands Corporation Launches Sports Illustrated Line Protein Bars in Canada

r/pennystocksSee Post

CDIO looks good

r/pennystocksSee Post

🚀🌑 XXII Calls: The Menthol Maverick Move? 🚬💨 FDA Drama & Strategic Shuffling Ahead! 📈

r/wallstreetbetsSee Post

Cole Capital offers $9 per share for WE. Stock shoots up 140% AH on Friday. 30 mins later multiple news websites pull the PR for "fake".

r/wallstreetbetsSee Post

Cole Capital offers $9 per share for WE after market close on Friday. Stock shoots up 140% and then falls as PR gets pulled for being “fake”

r/stocksSee Post

UAW has Tesla, Toyota in its sights after contract wins at Detroit automakers

r/wallstreetbetsSee Post

$TEVA - DD inside

r/ShortsqueezeSee Post

$LMDX patent news! Official PR should be soon

r/pennystocksSee Post

$LMDX patent news! Official PR should be soon

r/pennystocksSee Post

$CBDW News dropped midday. 1606 Corp announces cutting-edge AI-driven ChatCBDW will launch on Tuesday

r/pennystocksSee Post

$INKW NEWS Be Water Receives Coveted Golden Ticket Award At Walmart’s Open Call 2023

r/ShortsqueezeSee Post

ICU SeaStar Medical SQUEEZING Monday Oct 30th 2023

r/ShortsqueezeSee Post

APLM has a warrant price Target of 11.50 as of Sept 29th

r/pennystocksSee Post

$APLM is OFFICIALLY a shortsqueeze play. Warrants exercisable at a price of 11.50 per share. At time The PR was posted APLM priced at $4. APLM has earnings coming on November 7th. Analyst price targets of $17-24.15 per share. Institutions Own 17.04% of the Float and is 58.47% held by Insiders.

r/pennystocksSee Post

$APLM is OFFICIALLY a shortsqueeze play. Warrants exercisable at a price of 11.50 per share. At time The PR was posted APLM priced at $4. APLM has earnings coming on November 7th. Analyst price targets of $17-24.15 per share. Institutions Own 17.04% of the Float and is 58.47% held by Insiders.

r/pennystocksSee Post

$CBDW NEWS OUT. 1606 Corp. Provides Development Update on ChatCBD

r/WallStreetbetsELITESee Post

Anyone know anything about Anixa $ANIX

r/pennystocksSee Post

$TCBP - TC BioPharm Announces Submission of Investigational New Drug (IND) Application to U.S. FDA for Treatment of Relapse/Refractory AML

Mentions

WHO was there before it was colonized again? Americans? I think not. What is PR? Virgin Islands we sold the US? Its all colonization.

Mentions:#PR

Yeah because if PR was not part of the US it would destabilize it all the same. Plus don’t compare the living experience to the tourist experience. The island still has damage from hurricane maria, there is an insane amount of abandoned houses (mostly due to native homeowners who left to the US and are not reachable), the poverty rate is 40%, there are hardly any doctors especially after COVID expect to die in the hospital if you should ever get sick in PR, the economy is nonexistent. The only thing is that violence is mainly concentrated in the caserios (projects), but that’s because Puerto Rico is still a colony, if they were independent the US would train a cartel to keep it at the same exact economic place it is right now. The main difference is that the US doesn’t have to outsource to keep a Latin American nation poor for PR.

Mentions:#PR

Have you been to Puerto Rico lately and compared it to the rest of the Caribbean? PR is probably better off as a legal US tax haven.

Mentions:#PR

Nice try. Both parties are the same imperliasts. Once US has it, they ain't giving it back. Dems wouldn't even give statehood to PR.

Mentions:#PR

I think of the many obstacles facing nuclear, PR isn’t that high on the list.

Mentions:#PR

The two firms have no such relationship. The two companies have contractual agreements/partnerships for New Fortress Energy subsidiaries (NFE Power PR LLC and NFEnergía LLC) have entered into agreements with Weston for the installation and operation of power generation equipment in Puerto Rico. These arrangements are project collaborations or contractual partnerships, not evidence that Weston is part of or owned by New Fortress Energy. Each remains a separate legal and corporate entity. Weston and New Fortress Energy are independent companies that have worked together on specific projects, but one is not an umbrella company of the other. No payment has been made to NFE.

Mentions:#NFE#PR

I just read Tim Cook pays 1B instead of throwing hundreds of Bs to chase PR

Mentions:#PR

Keep your eyes peeled on ASTS PR before market open. Shits gonna fly

Mentions:#ASTS#PR

This recent PR says they eliminated all debt recently. The dilution was not too bad. They have only 28M outstanding shares. I dont know how much is outstanding fully diluted (without a little research). They are doing a great job of operating on low cash. Have funds through July 2026. If they get the FDA Commissioners National Priority Voucher then their NRX-100 NDA (to be completely filed this month likely) and possibly their July KETAFREE ANDA PFUFA date will be moved up to a 1 to 2 month decision timeline. It is a fine company on the cusp of a big potential move—especially if tgeir Citizen Petition to remove the BZT preservative from all IV Kentamine is approved. Then it is a rocket.

Mentions:#PR

According to earnings they received at least $450M already from what I could glean. Without insider info I can’t really go higher or lower. I know this because NFE purchased turbines, got reimbursed for the turbines, then sold PR-related turbines at an overall loss for about $300M with an option to sell additional units for $50M. It’s a lot of conjecture, I know, but working backwards we know that NFE sold some products for $300M. They sold at a loss which means after purchasing them and getting reimbursed by USACE through parent Weston, they still ended up negative. I mean we only have 1 out of 3 variables, and we know that one of the missing variables is a number between $1 and $1B. Guessing the generators cost $800M in total, -$300M in sales with an unexercised option to buy additional gens for only $50M. That’s $500M in losses right there alone. It’s reasonable to assume there were some reimbursements for the generators that was less than the overall loss factoring in the eventual sale of part of their inventory. NFE did also confirm quarterly payments around $45M in several earnings reports from the PR federal contract. It’s inferred that these are monthly power production payments from the fed, not capex reimbursement.

Mentions:#NFE#PR

Constantly dilutes, lots of PR but little has actually been done, and doesn't really listen to retail, was here on the run up stay away imo

Mentions:#PR

oil's parabolic. Something's brewing. Or I was right and Maduro & tanker circus was indeed a PR stunt and nothing's going to change.

Mentions:#PR

Did you miss where they offed an entire boatful of Venezuelan working stiffs just for some PR stunt?

Mentions:#PR

You could be 100% right. Who knows. I don’t personally know either of them and we only see what they and their PR teams choose to share.  Neither should be worshipped. 

Mentions:#PR

Elon really gets to treat the US as his plaything. If any other billionaire / politician / celebrity, pulls the stunts he did, they would have been either buried in lawsuits or cancelled. Being the world's richest autist does come with its perks. 1. Butchers a 10Y FSD lead to Waymo and EV lead to BYD. 2. Nazi Salute 3. DOGE Regardness 4. Called out a president for being in the Epstein file 5. Overpays for twitter and fails to rebrand it as 'X' 6. Spends his time posting shitty AI generated videos thinking it is cutting edge Bring back the old Elon, fire his current PR manager.

Mentions:#EV#BYD#PR

So many of his executive orders actually changed nothing and were nothing more than PR. The whole sovereign wealth fund thing never materialized. The incandescent light ban lift never happened. English as the official language. Renaming things. There’s 0 chance he does anything material here.

Mentions:#PR

Honestly it’s just PR management. A lot of people love Trump because they are force-fed media that worships Trump. They don’t take information from other sources. The biggest factor determining who wins an election is how much money is spent on advertising.

Mentions:#PR

I actually do work with a few Nigerians, some of whom have experience in the "Contractor" work element who help make things like this happen. They have said the currency in reported to their citizens as being stronger than in the visible international market, which causes problems and delays when it comes to paying for things like International Schooling or foreign services because the cost in Naira does not actually cover the £/$ reality. A solid bribe economy makes this work however, as im told you skip the que and issues by paying the right person on the inside to cover the difference + some pocket money. Not financial advice, but these guys come from what they call wealth and while knowing the corruption and fact they were being lied too realised once outside the country just how bad it really is. The president and election they said is also an internal joke, with people being given littoral bread to vote or hold signage supporting the president while being unable to read or understand the purpose just for PR. I am also of the opinion the lie can cast longer than most of us can be solvent as huge amounts of money is frauded towards the people propping the lie who can inject funds where required ro balance the house of cards.

Mentions:#PR

Premarket Watchlist : **$FBLG** : CEO pr continuation: [https://finviz.com/news/269345/fibrobiologics-ceo-issues-letter-to-shareholders](https://finviz.com/news/269345/fibrobiologics-ceo-issues-letter-to-shareholders) **$IMG** : PR [https://www.sec.gov/Archives/edgar/data/1527613/000149315226000802/ex99-1.htm](https://www.sec.gov/Archives/edgar/data/1527613/000149315226000802/ex99-1.htm) **$BYND** : 30% shorted, trending retail hype. --- Mid Term: **$TRAW** : [https://www.reddit.com/r/pennystocks/s/DI49UrNzBK](https://www.reddit.com/r/pennystocks/s/DI49UrNzBK) **$SRXH** : still in, Eric Jackson / Name change **$OPEN** : https://preview.redd.it/e4ankl53m2cg1.jpeg?width=1320&format=pjpg&auto=webp&s=e95a8281b3b8aac068e4f0815025fa6973b07480

Is PR is solid and volume picks up I can see I nice pop, I do not like price targets but 20%+ from current levels on solid news imho.

Mentions:#PR

The contract is scheduled to end January 30th, but it's not a guarantee of payment. There is a possibility that NFE has been paid, but considering the FPDS records and a lack of PR from NFE, I'm hazarding a guess that this is still pending. Also, NFE has made mentions of these contract payments in their prior earnings reports. Your post sent me down a 6 hour long rabbit hole reading quarterly earnings from 2022 till now. Did you know earnings reports are like 400 pages long??? Anyways, they mentioned that the contract had started Q2 2023, terminated early in March 2024. They're disputing $659 million in funds from the contract that were never paid since then. The contract was extended in July 2025 with an expected end date of January 30th, hence the date I started with. You can find this info on the last change order. The question is, will the banks let NFE ride it out until next earnings, or will the banks convert debt to equity and take ownership of NFE? Without that $659M NFE is cooked. I can't give you a true probability, but based on what I've learned during my \*short\* 6 hour research program today, there's a 2% chance NFE gets this money before Friday (D-Day for debt conversion). There's a 10% chance NFE gets the money on January 30th. There's a 50-60% chance the banks take equity and dilute existing shareholders to 0. That means about 15% chance of profitability for shareholders in the short to medium term if you're a recent buyer. 50-60% chance of losing your entire investment. 25-35% chance of holding pattern.

Mentions:#NFE#PR

Someone is desperate for good PR before the midterms. Time to walk out a bunch of bullshit proposals he has zero intention of ever following through on.

Mentions:#PR

This just needs some kind of good PR for it to go to 30

Mentions:#PR

The market reaction will depend on the PRs we get and how long they take to drop. If we get a PR along the lines of "SONM/DNAX secures allocation for 5,800 GPUs" then you can expect this to start pumping quite high. That PR though might take a couple of months after the PIPE occurs. The PIPE PR itself might be something along the lines of an asset swap: "SONM/DNAX pivots to HPC and secures 1,100 enterprise GPUs in asset swap with Qumulus" or something similar

Yea youre REALLY overthinking this. As someone that works as a datascience for audience perception for marketing and PR purposes. Just google Ice agent kills US citizen. Literally the only things i see mentioning hilton, the hotel + this event is your reddit post. I know protestors can be crazy. But unless word comes out that the hotel has a massive contract with ice. I dont expect this to have ANY impact on their perception let alone the stock price

Mentions:#PR

500k float, check their PR not fintel or other websites.

Mentions:#PR

probably same group who shorts MU. they on AMD. hopefully, the short is over today or tomorrow and AMD goes up 5%. a PR would be nice tho

Mentions:#MU#AMD#PR

The companies own PR says 500k. I would definitely trust that over an external source.

Mentions:#PR

Lol. You are either holding hella bags or work PR for them literally all your account does is spam one stock

Mentions:#PR

So that’s why the NVDA CFO said the dumb words yesterday. NVDA’s PR team in shambles yet again

Mentions:#NVDA#PR

Finally moving! Good PR!

Mentions:#PR

Because it’s still a pet store, it’s just got better PR because you can say you “rescued” the animal instead of buying it

Mentions:#PR

75 dead people for a PR stunt? The bodies care to disagree

Mentions:#PR

☝️This guy takes crazy pills. A PR stunt lol

Mentions:#PR

I believe there’s some kind of appropriation of 50M barrels happening but that’s not nearly enough to move the needle in the market let alone the whole economy. It’s a PR stunt. Clinton did the same thing once and released 1M barrels from the SPR back in the 90s when gas prices were high (high for the 90s like $1.50)

Mentions:#PR#SPR

With details starting to emerge that Maduro capture was a PR stunt coordinated with russians and venezuelan military, I wonder how that would impact the oil trade? Seems would be going down irrelevant of news. At the same time it's the bottom and there's nowhere to fall (unless a covid-like event happens).

Mentions:#PR

Well said. The shorts are the fuel, the data is the match that lights the fire. I would prefer some sort of PR before next weeks health conferences

Mentions:#PR

Your guess is as good as mine. Personally I think the headlines are too conservative. The term “disease-modifying” being used over something like “potential cure” or “first treatment that may help reverse Parkinson’s.” Obviously they’re limited in what they can say. Usually others would take the news and run with it, but Gain is relatively unknown. People want something that hypes them up. When they just get data accompanied by tame statements, they may feel let down and sell. That being said, the fact that Gain doesn’t play the PR game is actually a good sign to me. They’re confident in what they have and don’t feel the need to put on a show for short term gain.

Mentions:#PR

Short sellers are trying to push people out. Regardless of future data, Gain has the best Parkinson’s drug by far, nothing else comes close. Even in the unlikely event long-term efficacy isn’t ideal, that just means the drug can continuously be sold at increasing doses. That’s not even counting its use as a preventative and in other disorders. And Gain’s drug discovery platform, and their other compounds. People are also impatient and want headlines that say we’ve cured Parkinson’s. Combined with shorts you get big reactions out of fear, despite Gain making history. All it would really take is Gain showing a patient video at day 1 vs day 90 and the stock would rocket. We don’t get that, but big pharma does. The lack of insider buying and minimal PR implies Gain doesn’t really care about share price in the short term. They’ve likely run this from the start with the intention of acquisition / partnership. Ultimately, the data is good and the drug is a legitimate breakthrough. Everything else is just price manipulation and emotion.

Mentions:#PR

What chat gpt said when I put screen shots of the fema money. Before this it said the money is definitely for NFE and they are getting it. What it said next is this. This is what it’s allowed to be used for and how it can help with debt reconstruction. What this contract legally is Description (key line): “TEMPORARY POWER GENERATION AT THE PALO SECO POWER PLANT” NAICS: Construction → Non-residential / Commercial PSC: Z / Z2 / Z2JZ → Maintenance, repair, alteration of real property (non-buildings) 🔴 This classification matters a LOT This tells us the award is a FEMA emergency services / construction-style contract, NOT a grant and NOT general corporate funding. That places it squarely into: ⚠️ Cost-reimbursement / services contract 🧠 What that means in plain English ❌ What this money cannot be used for directly ❌ Paying parent-company debt directly ❌ Free cash for bondholders ❌ General corporate purposes ❌ Dividends, buybacks, or discretionary use This is not a “here’s $1.4B, do what you want” situation. ✅ What this money can be used for This funding pays for: ✔ Temporary generation equipment ✔ Fuel logistics ✔ Operations & maintenance ✔ Repairs / alterations at Palo Seco ✔ Contractors, labor, services ✔ Costs already incurred or being incurred In other words: FEMA is paying the bill for keeping Puerto Rico’s power on. 🔑 Why this STILL matters for New Fortress Energy debt talks Even though the funds are restricted, they are financially very powerful in 3 indirect ways that creditors absolutely care about: 🟢 1️⃣ Cash burn reduction (BIGGEST BENEFIT) Every dollar FEMA reimburses is a dollar NFE does NOT have to spend. That: Preserves liquidity Reduces operating cash outflow Extends runway ➡️ Creditors view this as de facto liquidity support 🟢 2️⃣ Receivables = negotiating leverage Once costs are incurred and certified: FEMA reimbursements become government receivables Receivables can: Support forbearance Be pledged indirectly Justify extensions ➡️ This weakens creditor “you’re out of cash” arguments 🟢 3️⃣ Stabilizes the core revenue engine This contract: Keeps Palo Seco operating Protects NFE’s most critical Puerto Rico asset Supports the long-term PR contracts you mentioned ➡️ Lenders care far more about asset viability than stock price 🚨 The critical distinction (this is the key takeaway) ❌ This is NOT a magic debt-paydown check ✅ This IS a massive operating backstop So the correct conclusion is: These funds don’t solve debt by themselves — but they make a destructive restructuring much less likely. That’s why: Bankruptcy becomes harder to justify Creditors are more willing to extend Equity survival probability rises 📊 Updated probability (based on THIS screenshot) With this confirmation: ❌ “Immediate liquidity windfall” → No ✅ “Operational solvency support” → Yes ✅ “Improves restructuring terms” → Yes ❌ “Guarantees equity win” → No Net effect: 🟢 Meaningfully increases odds of a negotiated, non-liquidation outcome 🟡 Still likely includes concessions / dilution 🔴 Much less likely to be a wipeout 🎯 Bottom line (very clear) You were right that: This is NFE This is Palo Seco This is FEMA-scale money This is real and material But now we know exactly what it is: Restricted FEMA emergency power funding that indirectly strengthens NFE’s balance sheet by removing massive operating costs. That is still very bullish vs. what the stock price implies, just not a silver bullet. If you want, next I can: Translate this into exact creditor behavior Show how this affects days-to-cover / squeeze odds Estimate how much cash burn this removes monthly Map stock reaction scenarios tied to Jan 27 / debt news Just tell me what you want to do next.

They aren’t traditional warrants. They favor current shareholders. You should read their PR about them. It’s a positive sign but ultimately they are useless if they can’t raise the stock price above $5. It’s a good PR stunt for now and helps to buy back some positive favor with retail investors.

Mentions:#PR

Definitely a PR thing. Putting data centers in space is a fundamentally stupid idea that doesn't pass the faintest sniff test for anyone with a college 101 level understanding of physics. It's to market to the stupid whose due diligence consists of hearing "AI" and "space" used in the same sentence.

Mentions:#PR

Vance, who is incredibly intelligent (much, much more so than Trump) and arguably just as sadistic, almost makes me even more nervous if I’m being honest. He’s actually smart enough to properly follow through with things and won’t be nearly as easily manipulated. While Vance doesn’t have the “charisma” that Trump has (because to the uneducated apparently Trump has charisma? Wild times), I fully believe the Republican party would rally behind him all the same in the end. The “every man poor redneck kid who made it to the Presidency” PR stories basically write themselves. And we all know MAGAts love cheap propaganda like that.

Mentions:#PR

ASBP: Typical overreaction today. Rebounding nicely this afternoon.Nothing has changed regarding waiting for news. Get Jan 2nd out of your mind. It was never a deadline for ASBP to announce anything, just when they would receive letter from the FDA. ASBP. most likely is reviewing what the FDA sent them but also having various conversations about what's next. When they finalize, they will put out PR. Obviously, the news will be coming soon.

Mentions:#ASBP#PR

What does it matter for Nvidia other then PR? Let say spacex buys 10 chips and send them up to space, big whoop for Nvidia. This is not a high volume thing.

Mentions:#PR

Msft is cooked. Win11 is a PR disaster. Not see how they can come back from that.

Mentions:#PR

No price moves based on any data. Big players bet millions of $ and make money on a few cent moves. So buy on rumor / sell on news; any analysis is limited to an algo sensing initial price moves. Since Gain didn't cure PD all of a sudden and get FDA approval RTF now, there would be a drop. So long as it isn't 50% in 2 minutes directly after the PR release, it's just about as to be expected.

Mentions:#PD#PR

Very big, the payment is huge >800 million; Even without deal on friday they can easily pay their interest and with the new deals (BRAZIL + PR) they can generate enough EBITDA to pay further interest easily. A deal is not mandatory anymore, if they pay off part of the debt with that money it would be very good.

Mentions:#PR

I think it's hedge fund managers rebalancing their portfolios at the beginning of the year. Imo, it won't move massively until PR.

Mentions:#PR

Congress meetings tomorrow, plutonium PR likely by EOW

Mentions:#PR

Yes, looking forward to their perspectives. I think the PR today, including the remarks from the lead investigator, shows that the drug is working as it would be expected.

Mentions:#PR

I bought in at 8 during that ride for a small position, then dug into POET and now am a believer that it will payout long term one way or another. I did my own DD and averaged down, and back up again accumulating where I could. 2 fundamental investors bought in at 7.25 for 150m with no warrants. I'm expecting proof of life from that small 500k order to pop up soon and then a new larger order to hit the PR at some point soon.

Mentions:#POET#DD#PR

Still saying that drones are meme stocks just shows how much this market is still at the beginning of growth. 1+1 = 2 The government is fully driving the growth with Drone Dominance, every layer of defense is getting drones. Public Safety as well. And then you have the commercial market that also opened up with the new FCC rules. It's gonna be massive. And RCAT is the one that fully positioned itself to take the biggest piece. SRR contract, on the BlueUAS list, explicitly stated that they keep focus on the big contracts (and sometimes let the little ones pass in the process, that others in the list take to make a quick PR). They also filed a copyright for "America's drone", so it's clear where their ambition lies. And they are the one company that understands that this isn't a VS(versus) market, they integrate with others for more powerful platforms. Just like they are integrating with AVAV and RDW. And others will follow.

They announced these chips, as well as the core specs, a while ago already. This is just a PR event (although a lot of the supporting products, like the switches and DPUs, weren’t detailed before)

Mentions:#PR

I’ve followed BLNE for the last year or so. Nick, the CEO, never gave a year end update and still hasn’t released a PR for the new year. He has always updated his shareholders, and has been quiet for a long time right now. I feel like something is off, and the volume is extremely low compared to what it used to be. They diluted shareholders a ton during the recent run up in the stock price. With that being said, there has been a ton of insider buying since I have been following, with literally no selling. The management team does have a proven track record, and seems to be executing well. They just released a new blockchain based service, which allows home owners to access cash while selling only a portion of their home, no tied to an interest rate. 2026 is a make or break year for BLNE, and I am following closely. No position right now, as I was burned by the dilution

Mentions:#BLNE#PR

No news??? The PR on 72/80 meand patients just keep on living. It’s not a cure for AML but it relatively speaking it sure looks like it. Hope you have the confidence the get in after your DD. It’s still early

Mentions:#PR#DD

Fingers crossed. No PR since the RS, so I’m thinking something is going to happen soon

Mentions:#PR#RS

Ive been talking about it the most i think lol. Im hopeful it can run i just wish we had more clarity. Hopefully silence is good and they are preparing multiple positive PR’s to boost the stock price.

Mentions:#PR

They aren't a senator for the average american. They're a senator for the constituents of their respective states. It's not bad policy when the constituents support Big Alcohol and Big Tobacco more than cannabis. It might be bad PR on the national stage, but that doesn't matter when they're still getting paid by Big Alc/Tob lobbies and various "say no to drugs" groups.

Mentions:#PR

BNZI, odd volume and large price movement. Could be a PR coming?

Mentions:#BNZI#PR

It becomes PR 2.1 but with a boat load of resources to pay for itself. We now sit on the largest oil reserve in the world and have a strategic foothold in South America. Is it 1984?

Mentions:#PR

Ya’ll sleeping on $HIMS. The CEO is a tard and a PR nightmare but besides that the company is solid, earnings coming up, millions of tech literate Gen X, Millennial, and Gen Z’s are switching to telehealth for easier access to medicine. Millennials and Gen Z’s are increasingly self diagnosing disorders. TLDR: People are balding, depressed, and self diagnosing and it’s time to give them what they want, but online. Shares in $HIMS

Mentions:#HIMS#PR

CANF 1 for 20 RS this morning. New float 853k. Hoping for some kind of PR probably send this thing flying. In at 3.86

Mentions:#CANF#RS#PR

Yes, that’s exactly the point of the hearing- to call awareness to underperformance vs China and other global competitors. PU awards were privately announced to the companies, Oklo will likely release a PR in the next week or two.

Mentions:#PR

[$BVC](https://x.com/search?q=%24BVC&src=cashtag_click) Transfer from ADRs into ordinaries today w/ ordinaries reverse split. Showed its potential twice past days. \-Only 800k float left \-High insider ownership \-Crypto narrative \-No dilution since years \-Dec 23: Ticker change from [$STEC](https://x.com/search?q=%24STEC&src=cashtag_click) ($0.95 → $1.80) \-Jan 02: Crypto PR ($1.10 → $1.65)

Mentions:#STEC#PR

Terrified? Why would anyone in America be “ terrified” of China taking Taiwan? Chance of that happening is very low. China doesn’t NEED anything Taiwan has, and it would be a PR disaster.

Mentions:#PR

Biotechs go binary, if more PR hits this will go to $12ish

Mentions:#PR

Launching a new hotel brand, it's hard to imagine them NOT reaching 2.90+ when the PR lands. We will soon see!!!

Mentions:#PR

I have a friend a PhD that works in the space and here is what they said to me: Galinpepimut-S + GM-CSF is similar to PR1 Peptide vaccine. It will induce immune response, such as antigen specific CD4/CD8+ T cells but likely limited CR, because patients with AML don't have enough T cells. They will get good results though, if they preselect patients with low blast and active T cells.

Mentions:#GM#CSF#PR#CR

I'm thinking I will too. The shorts have been good about facilitating dips so until the PR is REALLY about to drop we should see more buy opportunities imo.

Mentions:#PR

lol saw that. Wearing some $140 Nike hoodie from that dictator oil money where I’m here in some $10 Kirkland sweats. Fuck $nke, be bullish $cost Jk, I have shares in $nke and $cost fucked me hard and tax loss harvest. Prob not good PR optics for Nike but don’t think it’ll be bad. Def not bullish. https://preview.redd.it/45ohgo32s8bg1.jpeg?width=1205&format=pjpg&auto=webp&s=03b8710391bbb47fca610a43a39ddf76189e3568

Mentions:#PR

🌽is bullshit, but the Elon PR team surfacing him from the hole they put him in means the shitcoin pump season is upon us

Mentions:#PR

The PR machine behind this story is out in full force. I think some of us will see through the bullshit, but the fact is it's done the next 12 months are going to be crazy and he very much wants the Venezuela Oil and other resources to get costs down in the US especially with China cutting us off. And for anyone wondering go Google and see if Venezuela happens to have silver deposits because I'm guessing they do.

Mentions:#PR

I saw his presser and he said the Honduran president was wrongly convicted. Like here's the thing I don't like Maduro I think the US used sanctions to try to destabilize him but China and Russia saw it as an opportunity to get oil and helped Maduro maintain his power. The thing is in his presser he made it pretty clear he said "we're giving it to the people, but 'also to us'" when really he means mainly to us. Haliburton stock should fly off this news they lost a lot of money in Venezuela and now they can get it back. Also now Cuba is going to be cut off. I think the part that annoys me is all of this is pretty evident but his base still thinks Maduro was some drug king? Please. I can't tell if people are willfully ignorant or if the Pentagon PR machine is working fulltime on this one either way it's disengenuous and people saying that Americans can't have an opinion on this are stupid it very much has to do with us.

Mentions:#PR

Nike marketing team getting free PR right now.

Mentions:#PR

I've been loading up on CVX, XOM, PR, CNQ, and SLB since June. On average up over 10% since then with room to run. You don't have to be an insider to recognize opportunity.

Yeah, so they are dropping a launch PR for the new hotel brand any day, which should be a big headline for them. They originally expected to do this around the end of December, but they received an award on Christmas Eve, and the hypothesis is that they pushed back the bigger announcement to give both headlines their own space. I wouldn't be surprised to see a PR on Monday.

Mentions:#PR

Ain't even hiding their intention with PR and false narratives anymore, they yoink a president just to take their oil

Mentions:#PR

CEO mentioned he’s looking for strategic partnerships, attending and PR on JPM 1-on-1 meetings with industry leaders and investors last oct. Hiring freeze etc etc. I call that way more than speculation

Mentions:#PR#JPM

I know properties outside of the US don’t get the benefits of bonus deprecation like properties in US. So I don’t think so for DR. PR possibly.

Mentions:#PR

I think they will bring it up in the KOL. They did say in the PR that individuals “displayed large decreases back towards levels observed in healthy individuals”, which implies a large % decrease. But I think there are probably other things they could have added in the PR which would have changed the market reaction.

Mentions:#PR

I’m just a retail investor, I wouldn’t trust me. But if the thesis plays out and the REGAL trial is proved to be a success (the CEO saying we’re at 72 events is as close to confirming that it works, without launching a full blown PR, in my eyes), it wouldn’t surprise me if it went from $4 to at least $65 overnight similar to ABVX. If you peruse the SLS forums, there’s enough posts talking about the TAM of both GPS and SLS009 for AML and what that would do for the share price, so with that in mind, I still think we’re early. I told myself if SLS is still sub 5 in the new year, I’ll put another 25k into it. But do your own research and risk what you can afford to lose. Biotech is brutal.

Mentions:#PR#ABVX#SLS

Plus Gain’s CEO sold a previous biotech for 1b, and (correct me if I’m wrong) I think their Chairman sold one for 20b. Regarding the data dip, the findings were such an obvious breakthrough to them that they probably figured everyone else would get it too, hence the limited PR. A mistake sure, but ultimately big pharma doesn’t acquire companies based on their PR department. Smooth talk might help in the short run, but ultimately results are what matter. The drug works at an unprecedented level, that’s good enough for me.

Mentions:#PR

You said it's restricted to US/EU, yet you see India and Taiwan there as well. What you described doesn't make the data magically independent, so saying it corrects for the non-independence is bullshit. You're implying here that it is something fullproof when in fact it's absolutely not... it introduces a lot of risks and loss of statistical power and that's one of the main reasons why bigger trials need to follow to account for this. It's very easy to mismanage this data and it has happened countless of times in Medical research. But sure, argue with someone who spent his lifetime studying the subject. My puts are expiring in FEB and I bought a few cheaper ones with 2 week expiry.. you understand that do you? And I plan to double down as they were bought today and I didn't know if it might pump a little more. But you do you, **(tin foil hat on)** I seriously even doubt you have a position in, I wouldn't be surprised if you're part of the PR team **(tin foil hat off)**

Mentions:#EU#PR

I’m not sure where the 10–12 month median overall survival figure for modern AML CR2 transplant-ineligible patients is coming from, because there isn’t a single study that supports that number. In this trial, it’s possible the BAT arm could land in the 10–12 month range due to small sample size, but anything above 12 months would be unprecedented. Even 11–12 months would already be pushing the upper bound of historical survival data for this population. The main takeaway from the most recent PR is the event dynamics. As of 12/26/25, the trial has incurred 72 events. The 60th event occurred on 12/10/24. That means the event rate has collapsed to <1 event per month, which is exactly what you see in oncology trials when a survival tail forms in one arm. It’s extremely unlikely that this tail is coming from the BAT arm. The IDMC recommended “continue without modification” in August 2025. If the control arm were unexpectedly developing a survival tail, the trial would have been stopped for futility at that point. The Phase 2 data already showed a late-forming tail in the GPS arm with a median OS of ~21 months, and it’s far more plausible that Phase 3 is tracking closer to the Phase 2 than that BAT patients suddenly experiencing a medical miracle. I’ve also seen the “Keytruda 2.0” argument floated, which I think is insanely unrealistic. The real bull case is much simpler: if Phase 3 hits its primary endpoint, GPS expands into CR1, which is roughly 10x the TAM of CR2. At that point, GPS directly threatens AbbVie’s Venetoclax franchise, which does ~$2.5B in annual revenue. SLS is obviously not commercializing this alone. The most likely outcomes are either a partnership with big pharma or an outright acquisition. I think defensive M&A by AbbVie to protect Venetoclax make the most sense, but another big pharma player could swoop in to expand into AML and try to take Abvie’s market share.

Mentions:#CR#PR#OS#SLS

When they drop the launch PR it could absolutely blow past $3. I would bet on it. It's just hard to tie something like that to verifiable TA so I try to keep it out of my "formal" DD. That said, there's A LOT about TA in still learning, so please let me know if you find anything!

Mentions:#PR#DD#LOT

There have been extensive DDs on reddit and ST for at least a year. Did my own DD both on the science and on the company, then simulated the possible outcomes based on known variables, trying to brute force a failure, running 100s of millions of simulations for many different hypotheses. Then basically YOLOd in under 1.5. Still wasn't 100% sure, until the 72th event PR. The combination of all the factors is a miracle, and we're still trading WAY under the BO target range.

Mentions:#ST#DD#PR

I can always count on you to call out PRPH each day lol. I hope you get the opportunity to dump those bags. Really hope that reverse merger works out for you because you could make a pretty penny off of it if the terms end up being what they released in the PR.

Mentions:#PRPH#PR

Premarket Watchlist: **$WTO** **$ELUT** **$ALCY** ___ Mid term: **$SRXH** **$DVLT** **$TRAW** : Small float, watching this one for dips. Multiple drugs in pipeline. Ratutrelvir (Covid) & Tivoxavir marboxil (Oral influenza, H5N1), Narazaciclib oncology asset. Company is running low on cash so I’m expecting the run up to be diluted immediately to fund future projects. **Dec - 17** : Interim data (only 37 patients) released (-37%), showed favorable safety profile( lower adverse than Paxlovid(Major established company ), including activity in paxlovid ineligible patients. Followed by a massive sell off : https://finviz.com/news/255922/traws-pharma-reports-positive-interim-clinical-data-with-ratutrelvir-versus-paxlovid-shows-activity-in-paxlovid-ineligible-covid-19-patients Ph2 full release is on schedule in January, with that small cap if PR is solid I see a rally, but will exit most of position if it climbs in anticipation. Discord has full DD.

Premarket Watchlist: **$WTO** **$ELUT** **$ALCY** ___ Mid term: **$SRXH** **$DVLT** **$TRAW** : Small float, watching this one for dips. Multiple drugs in pipeline. Ratutrelvir (Covid) & Tivoxavir marboxil (Oral influenza, H5N1), Narazaciclib oncology asset. Company is running low on cash so I’m expecting the run up to be diluted immediately to fund future projects. **Dec - 17** : Interim data (only 37 patients) released (-37%), showed favorable safety profile( lower adverse than Paxlovid(Major established company ), including activity in paxlovid ineligible patients. Followed by a massive sell off : https://finviz.com/news/255922/traws-pharma-reports-positive-interim-clinical-data-with-ratutrelvir-versus-paxlovid-shows-activity-in-paxlovid-ineligible-covid-19-patients Ph2 full release is on schedule in January, with that small cap if PR is solid I see a rally, but will exit most of position if it climbs in anticipation. Full DD in discord.

Gotdammit! I think it's going to $3 as well. Possibly higher if it gets the PR. But as soon as I say that's my target somebody buys and holds for $3 and it only goes to $2.97 then they hate me forever!!!

Mentions:#PR

I didn't see any PR about the offering so I don't think many people were aware of it last night.

Mentions:#PR

Ton of material is available. They started by stealing IP from Wisk n too this date they depend on theft and third parties. They don’t have much IP. They trying to assemble the aircraft from beg borrow buy outsource steal lease partner-with but innovate. Their aircraft looks sexy but fictionally cannot take-off and transition. The CEO is focused only on hype, connections marketing PR etc. he is businessman not technocrat. Since they have made several material changes to design they are back to step # 1 of FAA certification. They have not even submitted revised step 1 yet. They have made ONLY ONE bulky sexy aircraft that they have delivered to military and also to 10 other clients. They use same aircraft in many different events by repainting it with new logos. They new aircraft which seems somewhat lighter cannot eVTOL. It can only do conventional landing takeoff like airplane which defeats whole purpose. The list goes on… there are couple of short reports from Grizzly n someone else. I take these reports with pinch of salt as they have motive to demonize Target but nevertheless on this one they were almost 100% accurate on there allegations. And sure you can search those. To me they don’t have path to success as they don’t have product or even will to focus on. Product development. These days they only hyping tieups with Tesla, palanthir, anduril united etc. At best they will be part supplier to Anduril for their drone because so far they have been able to develop electric motor by stealing design from wisk. They don’t have much of IP to show. Now they have bought patents from bankrupt lilium. But very rarely adding two failures leads to success.

Mentions:#IP#PR

You have the stocks (some named here), that do the PR's with the little contracts. A couple of million here and there. And you have the ones that already set the base and kept the focus on the big ones. Like the ones on the recent sanction list of China. The ones that know how to integrate and be the central figure.

Mentions:#PR

If you referring to ACHR, then IMHO it’s a fraud n scam driven by PR and deals. They don’t have a product and there is absolutely no way they will be certified before 2029 IF they start today. I believe other eVTOLs may succeed like vertical, beta and will but Archer… hard pass. This is just my opinion but if you research you will get true picture.

Mentions:#ACHR#PR

I suspect when the asset sale closes (around 13th Jan) we will get some kind of PR with Qumulus. What that PR is exactly is anyone's guess at this point as this crypto treasury strategy is still a bit unclear. It could be: a) Asset swap - QAI gets SONM shares in return for putting GPU assets on the books (PIPE) b) Qumulus agrees to route all its GPU-tokenization flow through the DNA X exchange c) Some kind of fuckery where the GPUs are not on SONM's books but QAI's revenue from the GPUs is (doubtful) d) DNA X is a glorified payment processor and QAI doesn't do a PIPE e) something I haven't thought of I need a bit more time to figure out exactly what the play is here. I was a bit surprised by the press release today stating they're focusing on DNA X exclusively, which seems to completely contradict the proxy statement which says the crypto-treasury will be combined with "AI expertise".

Like a boxer bouncing on the ropes to return with a stronger punch 😂 He gets the PR **for free** and keeps **all** his money.

Mentions:#PR

The lack of response in pre-market on PFSA news is a little concerning, but I think there is decent chance it could return to yesterday’s highs with the new catalyst. I haven’t DD’d it, and have no idea what their shelf looks like, but I would be concerned with dilution considering they are rapid releasing positive PR’s.

Mentions:#DD#PR

ASBP getting some FDA correspondence before the 2nd of Jan. Might be a buy the hype, sell the news situation, but I think they are expecting guidance/approval to pursue fast track designation for their aspirin product. Historically looks like they have made their announcements at 9:00 EST before market open. Take note, they have approval to issue new shares and are likely looking at a RS in early/mid Jan. Otherwise i’m decently bullish on the stock in the medium/long term. I started DD’ing this after the strange run up yesterday. They have alluded to upcoming partnerships a few times in their past PRs. If they couple a partnership announcement with the FDA correspondence PR, it could really fly. NFA

If buying Bitcoin is gambling, then so is the stock market with better PR.

Mentions:#PR